|2.55||+0.05 / +2.00%|
As of 4:00pm ET
|2.55||0.00 / 0.00%|
The 6 analysts offering 12-month price forecasts for Array Biopharma Inc have a median target of 8.00, with a high estimate of 14.00 and a low estimate of 6.00. The median estimate represents a +213.73% increase from the last price of 2.55.
The current consensus among 7 polled investment analysts is to Buy stock in Array Biopharma Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.